Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Rosen

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
Gynecologic Oncology|May 11, 2010
Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutationDanielle Vicus, Amy Finch, Barry Rosen, et al.
Gynecologic Oncology|June 24, 2010
Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tubeDanielle Vicus, Amy Finch, Ilana Cass, et al.
Familial Cancer|September 16, 2016
Frequency of germline PALB2 mutations among women with epithelial ovarian cancerJoanne Kotsopoulos, Victoria Sopik, Barry Rosen, et al.
Gynecologic Oncology|June 21, 2012
Height, weight, BMI and ovarian cancer survivalJoanne Kotsopoulos, Joel R K Moody, Isabel Fan, et al.
Journal of Medical Genetics|October 4, 2011
Clinical impact of unclassified variants of the BRCA1 and BRCA2 genesMohammad R Akbari, Shiyu Zhang, Isabel Fan, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 16, 2020
The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on 10-year survival from advanced ovarian cancerSoyoun Rachel Kim, Joanne Kotsopoulos, Ping Sun, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|May 31, 2016
The optimal time for surgery in women with serous ovarian cancerJocelyn M Stewart, Alicia A Tone, Haiyan Jiang, et al.
Scientific Reports|September 2, 2016
CRISPR-Cas9 enables conditional mutagenesis of challenging lociJoel A Schick, Claudia Seisenberger, Joachim Beig, et al.
International Journal of Molecular Sciences|January 11, 2025
Genome Deletions and Rewiring of the Transcriptome Underlying High Antimonite Resistance in <i>Achromobacter</i> sp. SMAs-55Yanshuang Yu, Martin Herzberg, Aurora M Pat-Espadas, et al.
Gynecologic Oncology|July 7, 2009
Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriersDanielle Vicus, Barry Rosen, Jan Lubinski, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
Gynecologic Oncology|May 11, 2010
Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutationDanielle Vicus, Amy Finch, Barry Rosen, et al.
Gynecologic Oncology|June 24, 2010
Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tubeDanielle Vicus, Amy Finch, Ilana Cass, et al.
Familial Cancer|September 16, 2016
Frequency of germline PALB2 mutations among women with epithelial ovarian cancerJoanne Kotsopoulos, Victoria Sopik, Barry Rosen, et al.
Gynecologic Oncology|June 21, 2012
Height, weight, BMI and ovarian cancer survivalJoanne Kotsopoulos, Joel R K Moody, Isabel Fan, et al.
Journal of Medical Genetics|October 4, 2011
Clinical impact of unclassified variants of the BRCA1 and BRCA2 genesMohammad R Akbari, Shiyu Zhang, Isabel Fan, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 16, 2020
The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on 10-year survival from advanced ovarian cancerSoyoun Rachel Kim, Joanne Kotsopoulos, Ping Sun, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|May 31, 2016
The optimal time for surgery in women with serous ovarian cancerJocelyn M Stewart, Alicia A Tone, Haiyan Jiang, et al.
Scientific Reports|September 2, 2016
CRISPR-Cas9 enables conditional mutagenesis of challenging lociJoel A Schick, Claudia Seisenberger, Joachim Beig, et al.
International Journal of Molecular Sciences|January 11, 2025
Genome Deletions and Rewiring of the Transcriptome Underlying High Antimonite Resistance in <i>Achromobacter</i> sp. SMAs-55Yanshuang Yu, Martin Herzberg, Aurora M Pat-Espadas, et al.
Gynecologic Oncology|July 7, 2009
Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriersDanielle Vicus, Barry Rosen, Jan Lubinski, et al.
Pageof 15